Department of Radiology, G.B. Rossi University Hospital, University of Verona, Piazzale L.A.Scuro 10, 37134, Verona, Italy.
IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Musculoskelet Surg. 2022 Jun;106(2):169-177. doi: 10.1007/s12306-020-00687-3. Epub 2020 Nov 19.
The purpose of this study was to evaluate the cost-effectiveness of introducing cone-beam computed tomography (CBCT) in the management of the complex finger fractures with articular involvement.
We created a decision tree model simulating the diagnostic pathway of complex finger fractures, suggesting the use of CBCT as alternative to multi-slice computed tomography (MSCT), and we compared their clinical outcomes, costs, and cost-effectiveness for a hypothetical cohort of 10,000 patients. Measures of effectiveness are analysed by using quality-adjusted life years, incremental cost-effectiveness ratio, and net monetary benefit.
Diagnosis of a complex finger fracture performed with CBCT costed 67.33€ per patient, yielded 9.08 quality-adjusted life years, and gained an incremental cost-effectiveness ratio of 29.94€ and a net monetary benefit of 9.07 € at 30,000€ threshold. Using MSCT for diagnosis costed 106.23 €, yielded 8.18 quality-adjusted life years, and gained an incremental cost-effectiveness ratio of 371.15 € and a net monetary benefit of 8.09 €. CBCT strategy dominated the MSCT strategy. The acceptability curve shows that there is 98% probability of CBCT being the optimal strategy at 30,000€ threshold (1 EUR equal to 1.11 USD; updated on 02/02/2020).
CBCT in complex finger fractures management is cost saving compared with MSCT and may be considered a valuable imaging tool in preoperative assessment, allowing early detection and appropriate treatment. It shortens the time to completion of diagnostic work-up, reduces the number of additional diagnostic procedures, improves quality of life, and may reduce costs in a societal perspective.
本研究旨在评估在伴有关节累及的复杂手指骨折的治疗中引入锥形束 CT(CBCT)的成本效益。
我们创建了一个决策树模型,模拟了复杂手指骨折的诊断路径,提出将 CBCT 作为多层 CT(MSCT)的替代方法,并比较了这两种方法在假设的 10000 名患者队列中的临床结果、成本和成本效益。使用质量调整生命年来分析有效性测量,增量成本效益比和净货币收益。
使用 CBCT 诊断复杂手指骨折的成本为每位患者 67.33 欧元,获得 9.08 个质量调整生命年,增量成本效益比为 29.94 欧元,在 30000 欧元阈值下的净货币收益为 9.07 欧元。使用 MSCT 进行诊断的成本为 106.23 欧元,获得 8.18 个质量调整生命年,增量成本效益比为 371.15 欧元,在 30000 欧元阈值下的净货币收益为 8.09 欧元。CBCT 策略优于 MSCT 策略。接受曲线表明,在 30000 欧元阈值下,CBCT 策略有 98%的可能性成为最优策略(1 欧元等于 1.11 美元;更新于 2020 年 2 月 2 日)。
与 MSCT 相比,CBCT 在复杂手指骨折的治疗中具有成本效益,并且可以被视为术前评估的有价值的成像工具,可实现早期检测和适当治疗。它缩短了诊断工作流程的完成时间,减少了额外诊断程序的数量,提高了生活质量,并可能从社会角度降低成本。